Intramedullary nails versus distal locking plates for fracture of the distal femur: results from the Trial of Acute Femoral Fracture Fixation (TrAFFix) randomised feasibility study and process evaluation.
clinical trials
feasibility studies
femoral fractures
fracture fixation, internal
fractures, bone
randomized controlled trial
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
05 05 2019
05 05 2019
Historique:
entrez:
8
5
2019
pubmed:
8
5
2019
medline:
4
6
2020
Statut:
epublish
Résumé
This feasibility study and process evaluation assessed the likely success of a definitive trial of intramedullary fixation with locked retrograde nails versus extramedullary fixation with fixed angle plates for fractures of the distal femur. A multicentre, parallel, two-arm, randomised controlled feasibility study with an embedded process evaluation was conducted at seven NHS hospitals in England. Treatment was randomly allocated in 1:1 ratio, stratified by centre and chronic cognitive impairment. Participants, but not surgeons or research staff, were blinded to the allocation. Patients 18 years and older with a fracture of the distal femur, who their surgeon believed would benefit from internal fixation, were eligible to take part.Participants were allocated to receive either a retrograde intramedullary nail or an anatomical locking plate. The primary outcomes for this feasibility study were the recruitment rate and completion rate of the EQ-5D-5L at 4 months post-randomisation. Baseline characteristics, disability rating index, quality of life scores, measurements of social support and self-efficacy, resource use and radiographic assessments were also collected. The views of patients and staff were collected during interviews. Recruitment and data completion were lower than expected. 23 of 82 eligible patients were recruited (nail, 11; plate, 12). The recruitment rate was estimated as 0.42 (95% CI 0.27 to 0.62) participants per centre-month. Data completeness of the EQ-5D-5L at 4 months was 61 per cent (95% CI 43% to 83%). The process evaluation demonstrated that the main barriers to recruitment were variation in treatment pathways across centres, lack of surgeon equipoise and confidence in using both interventions and newly formed research cultures that lacked cohesion. A modified trial design, with embedded recruitment support intervention, comparing functional outcome in cognitively intact adults who have sustained a fragility fracture of the distal femur is feasible. The Wales Research Ethics Committee 5 approved the study (ref: 16/WA/0225). ISRCTN92089567; Pre-results.
Identifiants
pubmed: 31061043
pii: bmjopen-2018-026810
doi: 10.1136/bmjopen-2018-026810
pmc: PMC6502051
doi:
Banques de données
ISRCTN
['ISRCTN92089567']
Types de publication
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e026810Subventions
Organisme : Department of Health
ID : HTA/15/59/22
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1017
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/4
Pays : United Kingdom
Investigateurs
David Noyes
(D)
Peter Giannoudis
(P)
Ben Ollivere
(B)
Charlotte Lewis
(C)
Andrew McAndrew
(A)
Haroon Majeed
(H)
Damian Mcclelland
(D)
Ashwin Kulkarni
(A)
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: Matthew Costa is a member of the UK NIHR HTA General Board. Janis Baird received funding from Danone Nutrica Early Life Nutrition for a specific research study which aims to improve the nutrition and Vitamin D status of pregnant women and is collaborating with Iceland Foods Ltd to evaluate the impact fruit and vegetable availability on diet.
Références
J Surg Orthop Adv. 2008 Winter;17(4):271-81
pubmed: 19138501
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
Injury. 2006 Aug;37(8):691-7
pubmed: 16814787
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
Value Health. 2011 Mar-Apr;14(2):390-9
pubmed: 21402307
Trials. 2014 Jan 06;15:5
pubmed: 24393291
Trials. 2016 Jun 08;17(1):283
pubmed: 27278130
Health Technol Assess. 2018 May;22(25):1-148
pubmed: 29785926
J Clin Epidemiol. 2016 Aug;76:166-74
pubmed: 26898705
Age Ageing. 2011 Jul;40(4):423-9
pubmed: 21624928
Injury. 2000 Sep;31 Suppl 3:C62-3
pubmed: 11052383
Emerg Med J. 2015 Dec;32(12):906-8
pubmed: 26598627
Cochrane Database Syst Rev. 2015 Aug 13;(8):CD010606
pubmed: 26270891
Trials. 2017 Nov 14;18(1):538
pubmed: 29137679
J Clin Epidemiol. 2014 Aug;67(8):912-20
pubmed: 24811157
J Clin Epidemiol. 1994 Dec;47(12):1423-35
pubmed: 7730851
Trials. 2015 Sep 28;16:432
pubmed: 26416143
N Engl J Med. 1987 Jul 16;317(3):141-5
pubmed: 3600702
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
Bone Joint J. 2016 Jun;98-B(6):846-50
pubmed: 27235531
Soc Sci Med. 1991;32(6):705-14
pubmed: 2035047
Med Care. 2002 Sep;40(9 Suppl):V55-63
pubmed: 12226586